Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-11-03
2010-02-09
Kosar, Andrew D (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S317000
Reexamination Certificate
active
07659244
ABSTRACT:
The present invention relates to new rapamycin derivatives for the inhibition of cell proliferation. The compounds can advantageously target two proteins in dividing cells and interfere with cell cycle. There is thus provided derivatives of rapamycin in which the 42 position of rapamycin is linked to an amino acid or a peptide through a carbamate ester linkage. These rapamycin derivatives can be synthesized by reacting 42-O-(4-Nitrophenoxycarbonyl) rapamycin and an amino acid or a free amino peptide under basic conditions. These rapamycin derivatives can be used to inhibit the cell cycle and are therefore useful for treating cell proliferation disorders.
REFERENCES:
patent: 5385910 (1995-01-01), Ocain et al.
patent: 5411967 (1995-05-01), Kao et al.
patent: 6585764 (2003-07-01), Wright et al.
patent: 0509795 (1992-10-01), None
patent: WO 96/41807 (1996-12-01), None
patent: WO 03/057218 (2003-07-01), None
International Search Report and Written Opinion of the International Searching Authority, corresponding to PCT application No. PCT/CA2004/001918 dated Mar. 14, 2005.
Naicker Selvaraj
Sharma Sanjay K.
Woo Thomas
Jenkins Wilson Taylor & Hunt, P.A.
Kosar Andrew D
Quest Pharmatech Inc.
LandOfFree
Rapamycin peptides conjugates: synthesis and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rapamycin peptides conjugates: synthesis and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rapamycin peptides conjugates: synthesis and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4207048